| Primary |
| Hepatitis C |
44.7% |
| Chronic Hepatitis C |
28.0% |
| Prophylaxis |
10.6% |
| Hypertension |
4.4% |
| Diabetes Mellitus |
1.9% |
| Hyperlipidaemia |
1.4% |
| Insomnia |
1.3% |
| Hyperuricaemia |
1.1% |
| Constipation |
0.9% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Rash |
0.7% |
| Gastritis |
0.7% |
| Iron Deficiency Anaemia |
0.6% |
| Pyrexia |
0.6% |
| Product Used For Unknown Indication |
0.5% |
| Hepatic Cirrhosis |
0.4% |
| Adverse Event |
0.4% |
| Gastric Ulcer |
0.4% |
| Depression |
0.3% |
| Nausea |
0.3% |
|
| Rash |
11.0% |
| White Blood Cell Count Decreased |
10.8% |
| Product Quality Issue |
10.0% |
| Weight Decreased |
9.8% |
| Vomiting |
9.1% |
| Anaemia |
6.5% |
| Pyrexia |
6.0% |
| Nausea |
4.8% |
| Renal Impairment |
4.6% |
| Drug Ineffective |
3.7% |
| Drug Eruption |
3.0% |
| Underdose |
2.8% |
| Haemoglobin Decreased |
2.7% |
| Malaise |
2.5% |
| Platelet Count Decreased |
2.4% |
| Pruritus |
2.4% |
| Renal Disorder |
2.3% |
| Pain |
2.0% |
| Decreased Appetite |
1.9% |
| Influenza Like Illness |
1.9% |
|
| Secondary |
| Chronic Hepatitis C |
51.4% |
| Hepatitis C |
22.4% |
| Prophylaxis |
8.7% |
| Hypertension |
3.3% |
| Diabetes Mellitus |
2.0% |
| Hyperuricaemia |
1.4% |
| Hyperlipidaemia |
1.3% |
| Insomnia |
1.1% |
| Rash |
1.1% |
| Constipation |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Adverse Event |
0.8% |
| Depression |
0.7% |
| Gastritis |
0.7% |
| Gastric Ulcer |
0.6% |
| Product Used For Unknown Indication |
0.6% |
| Iron Deficiency Anaemia |
0.6% |
| Pyrexia |
0.6% |
| Hepatic Cirrhosis |
0.6% |
| Diarrhoea |
0.3% |
|
| White Blood Cell Count Decreased |
20.1% |
| Neutrophil Count Decreased |
13.0% |
| Rash |
9.6% |
| Anaemia |
6.1% |
| Renal Impairment |
6.0% |
| Retinopathy |
6.0% |
| Platelet Count Decreased |
5.4% |
| Vomiting |
4.4% |
| Neutropenia |
3.6% |
| Renal Disorder |
3.1% |
| Weight Decreased |
3.1% |
| Malaise |
2.8% |
| Haemoglobin Decreased |
2.5% |
| Pyrexia |
2.4% |
| Drug Eruption |
2.3% |
| Decreased Appetite |
2.2% |
| Erythema Multiforme |
1.9% |
| Nausea |
1.8% |
| Retinal Haemorrhage |
1.8% |
| Thrombocytopenia |
1.8% |
|
| Concomitant |
| Hepatitis C |
62.7% |
| Chronic Hepatitis C |
25.6% |
| Hypertension |
1.9% |
| Depression |
1.7% |
| Hiv Infection |
1.3% |
| Diabetes Mellitus |
0.8% |
| Hepatic Cirrhosis |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Chest Pain |
0.6% |
| Anxiety |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Hepatitis C Antibody Positive |
0.4% |
| Insomnia |
0.4% |
| Pain |
0.4% |
| Adverse Event |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Blood Pressure |
0.3% |
| Chronic Hepatitis |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Hepatitis C Virus Test Positive |
0.3% |
|
| Rash |
16.3% |
| White Blood Cell Count Decreased |
10.9% |
| Renal Disorder |
8.2% |
| Pyrexia |
7.5% |
| Vomiting |
6.8% |
| Rash Generalised |
5.4% |
| Renal Impairment |
5.4% |
| Toxic Skin Eruption |
4.8% |
| Drug Eruption |
4.1% |
| Erythema Multiforme |
4.1% |
| Renal Failure Acute |
3.4% |
| Anaemia |
2.7% |
| Colon Cancer |
2.7% |
| Fatigue |
2.7% |
| Herpes Zoster |
2.7% |
| Platelet Count Decreased |
2.7% |
| Pruritus |
2.7% |
| Weight Decreased |
2.7% |
| Diarrhoea |
2.0% |
| Headache |
2.0% |
|
| Interacting |
| Hepatitis C |
42.9% |
| Chronic Hepatitis C |
28.6% |
| Hiv Infection |
28.6% |
|
| Drug Interaction |
33.3% |
| Lactic Acidosis |
33.3% |
| Retinopathy |
33.3% |
|
